Stock Forecast

  Ion Beam Applications SA ( IBAB.BR) Stock. Should you Buy or Sell?    $ 15.66

-0.36 (-2.35 %)

Ion Beam Applications SA Analysis

Updated on 10-09-2022
Symbol IBAB.BR
Price $15.66
Beta 0.633
Volume Avg. $11.84 thousand
Market Cap $461.4 M
52 Week Range $13.62 - $20.45

Ion Beam Applications SA opened the day at $15.66 which is -2.35 % on yesterday's close. Ion Beam Applications SA has a 52 week high of $20.45 and 52 week low of $13.62, which is a difference of $6.83. We like to see positive, upward trending shares, preferably with momentum. Market capitalization is $461.4 M and total net profit is $312964000 which means the company is trading at 1.47 times profit to market capitalization. Theoretically, if you were to buy Ion Beam Applications SA for $461.4 M, it would take 15 years to get your money back. Ion Beam Applications SA are in the Medical Devices space which will have a sweet spot and industry standard for net profit multiples.

Price Chart

1 D | All


Ion Beam Applications SA Stock Forecast - Is Ion Beam Applications SA a Buy or Sell?

DCF ScoreStrong Buy
ROE ScoreNeutral
ROA ScoreNeutral
DE ScoreStrong Buy
PE ScoreStrong Buy
PB ScoreStrong Buy
Overall RecommendationStrong Buy

Growth and Value

PE Ratio 120.462
Dividend Yiel 0.012
Net Profit Margin 0.017

Valuing Ion Beam Applications SA

Price Book Value Ratio 4.742 Price To Book Ratio 4.742
Price To Sales Ratio 1.747 Price Earnings Ratio 100.097

How liquid is Ion Beam Applications SA

Current Ratio 1.119
Quick Ratio 0.507


Debt Ratio 0.823 Debt Equity Ratio 4.656
Long Term Debt To Capitalization 0.336 Total Debt To Capitalization 0.400

Latest news about Ion Beam Applications SA

About Ion Beam Applications SA

CEO : Mr. Olivier Legrain
Sector : Healthcare
Industry : Medical Devices

Website :

Exchange : Brussels

Description :

Ion Beam Applications SA develops, manufactures, and supports medical devices and software solutions for cancer treatments in Belgium, the United States, and internationally. The company operates through Proton Therapy and Other Accelerators, and Dosimetry segments. The Proton Therapy and Other Accelerators segment develops, fabricates, and services medical and industrial particle accelerators, and proton therapy systems. This segment also offers turnkey solutions for the treatment of cancer through the use of proton beams; and a line of cyclotrons used for the production of positron emission tomography or SPECT radioisotopes, as well as a line of industrial accelerators for sterilization and ionization. The Dosimetry segment provides solutions and services that enhances efficiency and minimizes errors in radiation therapy and medical imaging quality assurance and calibration procedures. The company has strategic research and development partnership with SCK CEN (Belgian nuclear research center) to enable the production of Actinimum-225 (225Ac), a novel radioisotope for the treatment of cancer; and an agreement with University of Pennsylvania for advance research in ConformalFLASH. Ion Beam Applications SA was incorporated in 1986 and is headquartered in Louvain-la-Neuve, Belgium.

My Newsletter

Sign Up For Updates & Newsletters